Package 51672-4125-1

Brand: carbamazepine

Generic: carbamazepine
NDC Package

Package Facts

Identity

Package NDC 51672-4125-1
Digits Only 5167241251
Product NDC 51672-4125
Description

100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4125-1)

Marketing

Marketing Status
Marketed Since 2009-03-31
Brand carbamazepine
Generic carbamazepine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "48fd19fc-5d5b-0d24-e063-6294a90a0aa0", "openfda": {"nui": ["N0000008486", "N0000175751", "N0000185506", "N0000191266", "N0000187064", "N0000185507", "N0000185607"], "upc": ["0351672405014", "0351672412418", "0351672404741"], "unii": ["33CM23913M"], "rxcui": ["197442", "199378", "308973", "308976", "308979", "402505", "402506"], "spl_set_id": ["0526a054-3eda-49b4-b390-7d5d16e30af8"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Mood Stabilizer [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4125-1)", "package_ndc": "51672-4125-1", "marketing_start_date": "20090331"}, {"sample": false, "description": "1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4125-3)", "package_ndc": "51672-4125-3", "marketing_start_date": "20090331"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4125-6)", "package_ndc": "51672-4125-6", "marketing_start_date": "20090331"}], "brand_name": "Carbamazepine", "product_id": "51672-4125_48fd19fc-5d5b-0d24-e063-6294a90a0aa0", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "51672-4125", "generic_name": "Carbamazepine", "labeler_name": "Sun Pharmaceutical Industries, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Carbamazepine", "active_ingredients": [{"name": "CARBAMAZEPINE", "strength": "400 mg/1"}], "application_number": "ANDA078115", "marketing_category": "ANDA", "marketing_start_date": "20090331", "listing_expiration_date": "20271231"}